Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysis

Adem, Fuad; Abdela, Jemal; Edessa, Dumessa; Hagos, Bisrat; Nigussie, Abraham; Mohammed, Mohammed A.

doi:10.1186/s40545-021-00312-z

Journal of Pharmaceutical Policy and Practice

Table 1 Quality assessment of the included studies

References	JBI’s critical appraisal checklist, 2017
References	Q1	Q2	Q3	Q4	Q5	Q6	Q7	Q8	Q9	Q10	Q11
Mohammednur et al. 2014 [45]	Yes	Yes	No	yes	No	No	Yes	No	NA	NA	NA
Gebre et al. 2017 [34]	Yes	yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Gobezie et al. 2014 [46]	Yes	Yes	No	Yes	No	Yes	Yes	Yes	NA	NA	NA
Gobezie et al. 2013 [24]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	Yes
Aster et al. 2019 [26]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	Yes
Yaschilal et al. 2014 [43]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	NA
Abadir et al. 2015 [47]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Gashaw et al. 2016 [54]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Yirga et al. 2015 [27]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	Yes
Tamene et al. 2014 [28]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	Yes
Bereket et al. 2014 [29]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Mohammed et al. 2016 [30]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Mequanent et al. 2014 [55]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Asgedom et al. 2016 [48]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Kaleab et al. 2015 [49]	Yes	Yes	No	Yes	Yes	No	Yes	No	NA	NA	NA
Eskinder et al. 2013 [33]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Hailu et al. 2015 [50]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Malede et al. 2018 [36]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	Yes
Beshir et al. 2017 [37]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Elham et al. 2017 [25]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Mohammed et al. 2014 [38]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Tadele et al. 2015 [53]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	Yes
Ayele et al. 2017 [41]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Tamene et al. 2017 [28]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Haymen et al. 2018 [40]	Yes	Yes	No	Yes	Yes	Yes	Yes	No	NA	NA	NA
Berhane et al. 2017 [31]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	Yes
Gobezie et al. 2013 [50]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	Yes	No	Yes
Yohannes et al. 2017 [41]	Yes	Yes	No	Yes	Yes	No	Yes	No	NA	NA	NA
Bereket et al. 2013 [32]	Yes	Yes	No	Yes	Yes	Yes	Yes	Yes	NA	NA	NA
Gizachew et al. 2018 [44]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	Yes
Gubae et al. 2017 [39]	Yes	Yes	No	Yes	Yes	No	Yes	Yes	NA	NA	NA
Gosaye et al. [33]	Yes	No	No	Yes	Yes	Yes	Yes	UC	Yes	No	Yes

NA not applicable, UC-unclear; Q1-11, JBI's Critical Appraisal Checklist for Cohort studies [Q1: Were the two groups similar and recruited from the same population? Q2: Were the exposures measured similarly to assign people to both exposed and unexposed groups? Q3: Was the exposure measured in a valid and reliable way? Q4: Were confounding factors identified? Q5: Were strategies to deal with confounding factors stated? Q6: Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? Q7: Were the outcomes measured in a valid and reliable way? Q8: Was the follow-up time reported and sufficient to be long enough for outcomes to occur? Q9: Was follow up complete, and if not, were the reasons to loss to follow up described and explored? Q10: Were strategies to address incomplete follow up utilized? Q11: Was appropriate statistical analysis used?]; Q1-8, JBI's Critical Appraisal Checklist for Analytical Cross-Sectional studies [Q1: Were the criteria for inclusion in the sample clearly defined? Q2: Were the study subjects and the setting described in detail? Q3: Was the exposure measured in a valid and reliable way? Q4: Were objective, standard criteria used for measurement of the condition? Q5: Were confounding factors identified? Q6: Were strategies to deal with confounding factors stated? Q7: Were the outcomes measured in a valid and reliable way? Q8: Was an appropriate statistical analysis used?]

Back to article page

ISSN: 2052-3211

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com